Derudover udviste patienter med svær sepsis, som blev behandlet med Xigris, et hurtigere fald i interleukin- 6 - niveauerne, en global inflammationsmarkør, svarende til en reduktion i det inflammatoriske respons.
Additionally, patients with severe sepsis treated with Xigris had a more rapid decline in interleukin-6 levels, a global marker of inflammation, consistent with a reduction in the inflammatory response.